Cargando…
Spillover adherence effects of fixed-dose combination HIV therapy
The impact of fixed-dose combination (FDC) products on adherence to other, non-fixed regimen components has not been examined. We compared adherence to a third antiretroviral (ART) component among patients receiving a nucleoside reverse transcriptase inhibitor (NRTI) backbone consisting of the FDC E...
Autores principales: | Kauf, Teresa L, Davis, Keith L, Earnshaw, Stephanie R, Davis, E Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295624/ https://www.ncbi.nlm.nih.gov/pubmed/22399848 http://dx.doi.org/10.2147/PPA.S28482 |
Ejemplares similares
-
Adherence and clinical outcomes of HIV patients switching to a fixed-dose combination regimen
por: Kruger-Swanepoel, Geziena E., et al.
Publicado: (2022) -
Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
por: Patel, Bimal V, et al.
Publicado: (2008) -
Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes
por: Böhm, Anna-Katharina, et al.
Publicado: (2021) -
Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
por: Fleming, Joshua W, et al.
Publicado: (2015) -
Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis
por: Wei, Qiran, et al.
Publicado: (2023)